Together, this suggests that oncogenic ABL-kinase signaling increases A1 protein levels, possibly to implement factor-independent cell survival, and that A1 may be a relevant player for tumorigenesis or drug responsiveness in BCR-ABL+ pre-B-ALL. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.